‘De-Escalation’ Using Micafungin for the Treatment of Systemic Candida Infection: Budget Impact in France and Germany

Value in Health- United Kingdom

doi 10.1016/j.jval.2014.03.1570

Full Text

Abstract

Available in

Categories

Occupational Health

Date

May 1, 2014

Authors

O. Odufowora-Sita

Publisher

Elsevier BV

Related search

Invasive Candida Bovina Infection, France

Emerging Infectious Diseases

Infectious Diseases

English

Pms21 - Budget Impact Model of Inclusion of Tofacitinib for the Treatment of Rheumatoid Arthritis in France

Value in Health

Occupational Health

English

Pmd148 - The Budget Impact of Global Telemedicine Solution in France

Value in Health

Occupational Health

English

T2 Magnetic Resonance (T2MR) Nanoparticle Diagnostic for Systemic Candida Infection

Science-Business eXchange

English

PDB21 Chart Audit and Budget Impact Analysis of Pasireotide Versus Second-Line Therapies in the Treatment of Cushing's Disease in Germany

Value in Health

Occupational Health

English

Micafungin at Physiological Serum Concentrations Shows Antifungal Activity Against Candida Albicans and Candida Parapsilosis Biofilms

Antimicrobial Agents and Chemotherapy

Infectious Diseases

English

Impact of Financial Crisis on Firms’ Capital Structure in UK, France, and Germany

Multinational Finance Journal

English

Ultraviolet-C Light for Treatment of Candida Albicans Burn Infection in Mice

Photochemistry and Photobiology

Theoretical Chemistry

English

Development of Fluconazole Suppositories for the Treatment of Candida Infection of Genitourinary Tract

Indian Journal of Pharmaceutical Education and Research

English